Pharmacokinetics, Dialysability and Safety of P03277 in Healthy Volunteers and in Patients With Impaired Renal Function

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 13, 2017

Primary Completion Date

February 1, 2019

Study Completion Date

August 23, 2019

Conditions

Renal InsufficiencyHealthy Volunteers

Interventions

DRUG

P03277

Single intravenous bolus injection at 0.1 mmol/kg body weight at a rate of 2 mL/second

Trial Locations (2)

Republican Clinical Hospital, Arensia EM Unit, Chisinau

"Arensia Phase I unit Carol Davila Nephrology Hospital", Bucharest